位置：成果数据库 > 期刊 > 期刊详情页
源于中药选择性效应的新型免疫抑制疗法。
  • 期刊名称：化学进展 2009; 21(1): 55-62。（IF=0.649）
  • 时间：0
  • 相关项目：调控活化T细胞的新分子靶标与选择性免疫抑制剂的基础研究
同期刊论文项目
调控活化T细胞的新分子靶标与选择性免疫抑制剂的基础研究
期刊论文 20 会议论文 39 获奖 2 著作 2
同项目期刊论文
Sorafenib inhibits activation of human peripheral blood T cells by targeting LCK phosphorylation.
Astilbin inhibits the adhesion of T lymphocytes via decreasing TNF-α and its associated MMP-9 activi
An Anticancer Effect of Curcumin Mediated by Down-regulating PRL-3 Expression on Highly Metastatic M
Involvement of Na+, K+-ATPase and its inhibitors in lung epithelial inflammation by HuR-mediated cyt
Selective triggering of apoptosis of concanavalin A-activated T cells by fraxinellone for the treatm
Saikosaponin a inhibits the proliferation and activation of T cells through cell cycle arrest and in
Sorafenib induces apoptosis of HL60 cells through inhibiting Src kinase mediated STAT3 phosphorylati
Jaceosidin inhibits contact hypersensitivity in mice via down-regulating IFN-γ/STAT1/T-bet signaling
Targeting Sarcoplasmic/Endoplasmic Reticulum Ca2+-ATPase 2 by Curcumin Induces ER Stress-Associated
Integrin a6high cell population functions as an initiator in tumorigenesis and relapse of human lipo
A novel regulatory mechanism of naringenin through inhibition of T lymphocyte function in contact hy
源于中药选择性效应的新型免疫抑制疗法